FDA lifts hold on first-ever CRISPR/Cas9 gene-editing trial
October 10, 2018 at 17:03 PM EDT
The FDA has lifted its hold on CRISPR Therapeutics and Vertex's Pharmaceuticals' highly anticipated gene editing trial Wednesday, allowing the first company-backed trial to soon start in the U.S.
